Literature DB >> 51917

[Eosinophil leucocytes in csf after myelography (author's transl)].

K Summer, U Traugott.   

Abstract

2 cases one of polyneuropathy and one of funicular myelosis, in which myelography was performed, are reported. After the insertion of the contrast medium an increase of eosinophil leucocytes was observed. In one case an additional increase of IgG and IgA, as well as a penetration of macromolecular proteins and an increase of the total protein, was detected. The second case showed an increase in haptoglobulin in addition to the cellular reaction described. After removal of the contrast medium, the CSF became normal in both cases. These changes were on one hand interpreted as a functional lesion of the barrier, and on the other hand as a special cellular and humoral immune reaction. This could be distinctly detected in the lumbar CSF while in the suboccipital CSF there was only an indication of it. This emphasizes the assumption of a pathological reaction in the section of the cerebrospinal region that was in contact with the contrast medium (allergen-hyperergic reaction of the vascular fibrous tissue of the leptomeninges). No marked changes were observed in the serum.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51917     DOI: 10.1007/bf00316384

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  [ON MACROPHAGOCYTOSIS IN THE CEREBROSPINAL FLUID].

Authors:  R M SCHMIDT
Journal:  Arztl Forsch       Date:  1964-03-10

2.  [On tumor cell diagnosis in the cerebrospinal fluid].

Authors:  H BAMMER
Journal:  Dtsch Z Nervenheilkd       Date:  1963

3.  [Changes of the peripheral blood picture and the sternal bone marrow in multiple sclerosis].

Authors:  R M SCHMIDT
Journal:  Med Monatsschr       Date:  1955-10

4.  [The results of the recent cytological studies of cerebrospinal fluid with sedimentation chamber].

Authors:  J SAYK
Journal:  Arztl Wochensch       Date:  1954-10-29

5.  Cysticercosis cerebri.

Authors:  S OBRADOR
Journal:  Acta Neurochir (Wien)       Date:  1962-05-28       Impact factor: 2.216

6.  [On the significance of eosinophilic leukocytes in neurologic diseases].

Authors:  O Kolár; W Zeman; J Ciembroniewicz; F Veselý
Journal:  Wien Z Nervenheilkd Grenzgeb       Date:  1969-05

Review 7.  On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system.

Authors:  W Tourtellotte
Journal:  J Neurol Sci       Date:  1970-03       Impact factor: 3.181

8.  [Immunologically important cell and protein findings in the cerebrospinal fluid in neuroallergic diseases].

Authors:  H J Meyer-Rienecker
Journal:  Psychiatr Neurol Med Psychol (Leipz)       Date:  1972-05

9.  [Experience with cerebrospinal fluid cell diagnosis. An analysis of approximately 5000 cerebrospinal fluid cytological studies. I. Normal cerebrospinal fluid cells, cerebrospinal fluid cell findings in primary and metastatic brain and spinal cord tumors, cerebrovascular disorders, as well as following head injuries with brain trauma].

Authors:  V Wieczorek; J Greger
Journal:  Psychiatr Neurol (Basel)       Date:  1965

10.  [On the cerebrospinal fluid cellularity in Boeck's meningitis].

Authors:  D Wilbrandt; P Hackenberg
Journal:  Nervenarzt       Date:  1967-09       Impact factor: 1.214

View more
  3 in total

1.  An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys.

Authors:  A A Hertler; D M Schlossman; M J Borowitz; D G Poplack; A E Frankel
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 2.  Eosinophilic granulocytes in cerebrospinal fluid: analysis of 94 cerebrospinal fluid specimens and review of the literature.

Authors:  I Bosch; M Oehmichen
Journal:  J Neurol       Date:  1978-10-25       Impact factor: 4.849

3.  [Eosinophilic meningomyelitis (author's transl)].

Authors:  H G Hoffmann; H W Kölmel; M Alexander
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.